Pharmaron Beijing Market Cap

Pharmaron Beijing has a market cap or net worth of 51.74 billion as of January 7, 2026. Its market cap has increased by 9.77% in one year.

Market Cap

51.74B

Enterprise Value

56.42B

Revenue

13.54B

Ranking

n/a

PE Ratio

36.19

Stock Price

31.26

Market Cap Chart

Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 51.74B, an increase of 614.73%. That is a compound annual growth rate of 32.72%.

Market Cap History

Date	Market Cap	% Change
Jan 7, 2026	51.74B	9.70%
Dec 31, 2025	47.16B	12.70%
Dec 31, 2024	41.85B	-11.66%
Dec 29, 2023	47.37B	-38.44%
Dec 30, 2022	76.95B	-27.67%
Dec 31, 2021	106.40B	12.84%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Jan 28, 2019	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	418.97B
WuXi AppTec	279.75B
Shenzhen Mindray Bio-Medical Electronics	241.39B
Sichuan Biokin Pharmaceutical	133.70B
Shanghai United Imaging Healthcare	108.89B
Aier Eye Hospital Group	103.93B
Zhangzhou Pientzehuang Pharmaceutical.,	102.74B
Yunnan Baiyao Group Co.,Ltd	102.27B

Market Cap Rankings